In vitro activity of quinupristin/dalfopristin and newer quinolones combined with gentamicin against resistant isolates of Enterococcus faecalis and Enterococcus faecium.
- 1 September 1998
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 17 (9) , 657-661
- https://doi.org/10.1007/bf01708351
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparative In Vitro Activity and Killing Effect of Trovafloxacin, DU-6859a, Levofloxacin and Sparfloxacin against Staphylococcus aureusClinical Drug Investigation, 1997
- Bactericidal activity of the fluoroquinolone DU-6859a alone and in combination with other antimicrobial agents against multiresistant enterococciPublished by Elsevier ,1996
- Quinupristin-DalfopristinDrugs, 1996
- Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against Gram-positive cocciJournal of Antimicrobial Chemotherapy, 1996
- Activity of two novel fluoroquinolones (DU-6859a and DV-7751a) tested against glycopeptide-resistant enterococcal isolatesDiagnostic Microbiology and Infectious Disease, 1995
- Activity of Quinolones against Gram-Positive CocciDrugs, 1995
- In Vitro Activity of Fluoroquinolones against Gram-Positive BacteriaDrugs, 1995
- Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteersAntimicrobial Agents and Chemotherapy, 1995
- In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1993
- In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridoneAntimicrobial Agents and Chemotherapy, 1993